Haemoglobin Mass and Running Time Trial Performance after Recombinant Human Erythropoietin Administration in Trained Men
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
UNLABELLED: Recombinant human erythropoietin (rHuEpo) increases haemoglobin mass (Hb(mass)) and maximal oxygen uptake (v O(2 max)). PURPOSE: This study defined the time course of changes in Hb(mass), v O(2 max) as well as running time trial performance following 4 weeks of rHuEpo administration to determine whether the laboratory observations would translate into actual improvements in running performance in the field. METHODS: 19 trained men received rHuEpo injections of 50 IU•kg(-1) body mass every two days for 4 weeks. Hb(mass) was determined weekly using the optimized carbon monoxide rebreathing method until 4 weeks after administration. v O(2 max) and 3,000 m time trial performance were measured pre, post administration and at the end of the study. RESULTS: Relative to baseline, running performance significantly improved by ∼6% after administration (10:30±1:07 min:sec vs. 11:08±1:15 min:sec, p<0.001) and remained significantly enhanced by ∼3% 4 weeks after administration (10:46±1:13 min:sec, p<0.001), while v O(2 max) was also significantly increased post administration (60.7±5.8 mL•min(-1)•kg(-1) vs. 56.0±6.2 mL•min(-1)•kg(-1), p<0.001) and remained significantly increased 4 weeks after rHuEpo (58.0±5.6 mL•min(-1)•kg(-1), p = 0.021). Hb(mass) was significantly increased at the end of administration compared to baseline (15.2±1.5 g•kg(-1) vs. 12.7±1.2 g•kg(-1), p<0.001). The rate of decrease in Hb(mass) toward baseline values post rHuEpo was similar to that of the increase during administration (-0.53 g•kg(-1)•wk(-1), 95% confidence interval (CI) (-0.68, -0.38) vs. 0.54 g•kg(-1•)wk(-1), CI (0.46, 0.63)) but Hb(mass) was still significantly elevated 4 weeks after administration compared to baseline (13.7±1.1 g•kg(-1), p<0.001). CONCLUSION: Running performance was improved following 4 weeks of rHuEpo and remained elevated 4 weeks after administration compared to baseline. These field performance effects coincided with rHuEpo-induced elevated v O(2 max) and Hb(mass).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Emerging biological roles for erythropoietin in the nervous system
Brines, M., & Cerami, A. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1687 · Cited by 523
Heme Degradation and Vascular Injury
Belcher, J. D., Beckman, J. D., Balla, G., Balla, J., & Vercellotti, G. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2822 · Cited by 257 · cited 1×
“This decrease in Hbmass and red cell volume post rHuEpo administration entailed the haemolysis of circulating red blood cells and therefore the release of heme from heamoglobin [45].”
Background
Cited by
Androgens and athletic performance of elite female athletes
Bermon, S. (2017) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000335 · Cited by 58
Sub-anesthetic Xenon Increases Erythropoietin Levels in Humans: A Randomized Controlled Trial
Stoppe, C., Ney, J., Brenke, M., Goetzenich, A., Emontzpohl, C., Schälte, G., Grottke, O., Moeller, M., Rossaint, R., & Coburn, M. (2016) · Sports Medicine · doi:10.1007/s40279-016-0505-1 · Cited by 31
“Previous studies demonstrated that recombinant administration of EPO in healthy volunteers takes about 2 weeks until a significant increase in hemoglobin of 6 % can be measured [40].”
BackgroundTour de France Champions born or made: where do we take the genetics of performance?
Moran, C. N., & Pitsiladis, Y. P. (2017) · Journal of Sports Sciences · doi:10.1080/02640414.2016.1215494 · Cited by 32
Self-citationDias, K. A., Lawley, J. S., Gatterer, H., Howden, E. J., Sarma, S., Cornwell, W. K., Hearon, C. M., Samels, M., Everding, B., Liang, A. S.-W., et al. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00289.2019 · Cited by 16
“This may have been due to the timing of measurements, as it has been previously shown that significant increases in hemoglobin of ~6% are only seen 2 wk after administration of recombinant EPO (4) or altitude training (5).”
Background
Metadata
- Authors
- Durussel, J., Daskalaki, E., Anderson, M., Chatterji, T., Wondimu, D. H., Padmanabhan, N., Patel, R. K., McClure, J. D., & Pitsiladis, Y. P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-02-13
- Volume
- 8
- Issue
- 2
- Pages
- e56151
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1989816640
- Cited by
- 62
- References
- 2
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.